로딩 중…
StockDiggingStockDigging

Repligen Corporation

RGEN· NASDAQ
$147.06+4.29%
2026-08-03

Financials

Valuation Metrics

Repligen Corporation's Market Cap is $8.30B. At end of 2025 it was $9.26B. Ranked #1054 of 3,112 in US market (top 34%), #343 of 1,445 on NASDAQ (top 24%), #72 of 206 in Health Care Equipment & Services (top 35%) by Market Cap.

Investment Metrics(as of 2026-08-03)

MetricValue
Size
Market Cap$8.30B
Revenue$785M
Net Income$42M
Total Assets$2.95B
Net Assets$2.11B
Employees2,000
Value
P/E199.70x
P/B3.93x
P/S10.57x
EV/EBITDA68.78x
FCF Yield1.34%
Profitability
ROE1.97%
ROA1.41%
Op. Margin8.32%
Revenue Growth11.93%
Earnings Growth-66.31%
Financial Health
Debt Ratio39.68%
Total Debt$691M
FCF$111M
Cash$607M
Current Ratio9.05x
Net Debt/EBITDA0.69x
Performance
1Y Return23.67%
1M Return3.27%
From 52W High-16.33%
1Y MDD-40.28%
Trading
Volume877,346 shares
Trading Value$127M
Per Share
EPS$0.86
BPS$37.26

Company Info

CEO Mr. Olivier Loeillot
Employees 2,000
HQ Waltham, United States

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.